In a significant policy shift, the US Olympic and Paralympic Committee has announced a ban on transgender women competing in women's sports, aligning with a controversial executive order from former President Trump. This move has sparked outrage among advocacy groups and raises questions about the future of inclusivity in athletics.
Coca-Cola is set to introduce a new version of its iconic drink sweetened with U.S. cane sugar this fall, responding to consumer demand for alternative sweeteners and aligning with President Trump's economic priorities.
In a surprising move, federal vaccine advisers have voted to remove thimerosal from flu shots, aligning with anti-vaccine activists. This decision raises concerns about vaccine availability and public health.
Apple has unveiled a groundbreaking change in its operating system naming convention at WWDC 2025, opting for a year-based system. This move promises clarity and consistency, aligning with competitors like Samsung and Microsoft. Discover the major design overhaul featuring a stunning 'Liquid Glass' interface!
In a surprising move, the White House announced it will withdraw Jared Isaacman's nomination to lead NASA, just days before a Senate vote. The decision highlights the administration's focus on aligning NASA's leadership with Trump's America First agenda.
FTC Chairman Andrew Ferguson is aligning the agency's focus with Donald Trump's agenda, leading to significant implications for major mergers, including the Microsoft-Activision deal.
Researchers have developed a groundbreaking biodegradable material from mycelium that is not only edible but also offers impressive functional properties. Discover how this living material could transform industries!
In a landmark move, President Trump signs an Executive Order aimed at reducing prescription drug prices for Americans, aligning them with those in other wealthy nations. This initiative seeks to curb unfair pricing practices and ensure a fair deal for U.S. patients.
President Trump is set to sign an executive order aiming to lower drug prices in the US by aligning them with prices in wealthy nations. This 'most favored nation' model could face legal challenges.
In a surprising announcement, Trump declares he will sign an executive order to slash prescription drug prices in the U.S. to match those of other high-income countries, potentially reducing costs by 30% to 80%.
